Letter: Co-trimoxazole in bubonic plague - PubMed (original) (raw)

Letter: Co-trimoxazole in bubonic plague

Nguyen-Van-Ai et al. Br Med J. 1973.

No abstract available

PubMed Disclaimer

Similar articles

• [Bubonic and septicemic plague successfully treated with trimethoprim-sulfamethoxazole (preliminary note)].
  Nguyen-Van-Ai, Nguyen-Duc-Hanh, Pham-Van-Dien, Nguyen-Van-Le. Nguyen-Van-Ai, et al. Bull Soc Pathol Exot Filiales. 1972 Nov-Dec;65(6):770-80. Bull Soc Pathol Exot Filiales. 1972. PMID: 4679266 French. No abstract available.
• F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy.
  Chanteau S, Rabarijaona L, O'Brien T, Rahalison L, Hager J, Boisier P, Burans J, Rasolomaharo M. Chanteau S, et al. Trans R Soc Trop Med Hyg. 1998 Sep-Oct;92(5):572-3. doi: 10.1016/s0035-9203(98)90923-3. Trans R Soc Trop Med Hyg. 1998. PMID: 9861385 No abstract available.
• [In vitro and in vivo effects of trimethoprim-sulfamethoxazole on Yersinia pestis].
  Nguyên-Van-Ai, Nguyên-Duc-Hanh, Pham-Van-Diên, Nguyên-Van-Lê. Nguyên-Van-Ai, et al. Bull Soc Pathol Exot Filiales. 1972 Nov-Dec;65(6):759-64. Bull Soc Pathol Exot Filiales. 1972. PMID: 4679265 French. No abstract available.
• Treatment of urinary infection with co-trimoxazole (trimethoprim-sulphamethoxazole).
  Gong NC, Chan KE, Singham KT, Chai KH. Gong NC, et al. Med J Malaysia. 1974 Mar;28(3):194-6. Med J Malaysia. 1974. PMID: 4278358 No abstract available.
• [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature].
  Gava R, Carli M. Gava R, et al. G Clin Med. 1989 Jan;70(1):37-9, 42-6. G Clin Med. 1989. PMID: 2668092 Review. Italian. No abstract available.

Cited by

• A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings.
  Bourner J, Andriamarohasina L, Salam A, Kayem ND, Randremanana R, Olliaro P. Bourner J, et al. PLoS Negl Trop Dis. 2023 Nov 9;17(11):e0011509. doi: 10.1371/journal.pntd.0011509. eCollection 2023 Nov. PLoS Negl Trop Dis. 2023. PMID: 37943880 Free PMC article.
• Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
  Wormser GP, Keusch GT, Heel RC. Wormser GP, et al. Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002. Drugs. 1982. PMID: 6759092 Review. No abstract available.
• Antibiotic treatment of experimental pneumonic plague in mice.
  Byrne WR, Welkos SL, Pitt ML, Davis KJ, Brueckner RP, Ezzell JW, Nelson GO, Vaccaro JR, Battersby LC, Friedlander AM. Byrne WR, et al. Antimicrob Agents Chemother. 1998 Mar;42(3):675-81. doi: 10.1128/AAC.42.3.675. Antimicrob Agents Chemother. 1998. PMID: 9517950 Free PMC article.
• Plague--clinical features and management.
  Kabra SK, Jain Y, Seth V. Kabra SK, et al. Indian J Pediatr. 1994 Nov-Dec;61(6):619-23. doi: 10.1007/BF02751965. Indian J Pediatr. 1994. PMID: 7721364 No abstract available.
• Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study.
  Salam AP, Raberahona M, Andriantsalama P, Read L, Andrianarintsiferantsoa F, Razafinambinintsoa T, Rakotomalala R, Hasiniatsy RNE, Razafimandimby D, Castle L, Funk A, Mangahasimbola RT, Renaud B, Bertherat E, Lovering A, Heraud JM, Andrianaivoarimanana V, Frédérique R, Razanajatovo N, Baril L, Fontanet A, Rajerison M, Horby P, Randria M, Randremanana R. Salam AP, et al. Am J Trop Med Hyg. 2020 Jun;102(6):1309-1315. doi: 10.4269/ajtmh.19-0576. Am J Trop Med Hyg. 2020. PMID: 32274983 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central